By |

Profile

4SC AG focuses on the development of novel small molecule drugs that can target key indications of cancer through epigenetic mechanisms. The company's product consists of resminostat, 4SC-202 and 4SC-208. The resminostat product generates maximum revenue for the company. It operates its business in Germany region.

Contact Information

Website: www.4sc.com
Email: yvonne.alexander@4sc.com
Main Phone: +49 897007630
Address: Fraunhoferstrasse 22
City / Town: Planegg-Martinsried
Country: DEU
Postal Code: 82152

Issuer Information

Exchange: GREY
Employees: 45


Gathering Data... Please wait

Profile

4SC AG focuses on the development of novel small molecule drugs that can target key indications of cancer through epigenetic mechanisms. The company's product consists of resminostat, 4SC-202 and 4SC-208. The resminostat product generates maximum revenue for the company. It operates its business in Germany region.

Contact Information

Website: www.4sc.com
Email: yvonne.alexander@4sc.com
Main Phone: +49 897007630
Address: Fraunhoferstrasse 22
City / Town: Planegg-Martinsried
Country: DEU
Postal Code: 82152

Issuer Information

Exchange: GREY
Employees: 45
$ 5.30 $ 0. (0.00%)
Last Price 5.30 Change $ 0. Change % 0.00 Tick N/A
Bid N/A Bid Size N/A Ask N/A Ask Size N/A
Open N/A High N/A Low N/A Prev Close 5.30
Last Trade Volume 0 52 Wk Hi N/A 52 Wk Low N/A
Market Cap 162.4 mi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 30,648,513.00 EPS (TTM) -0.67 PE Ratio N/A Exchange Greys